Acute Ischemic Stroke clinical trials

Explore recruiting acute ischemic stroke clinical trials.

Recruiting acute ischemic stroke studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Acute Ischemic Stroke trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Early treatment of Atrial fibrillation for Stroke prevention Trial in acute STROKE (EAST-STROKE)

Spain, Germany, Netherlands

Therapeutic use (Phase IV) EU CTIS Study details

Thrombolysis with Tenecteplase for Acute Ischemic Stroke in Patients taking Direct Oral Anticoagulants – a multicentre randomised placebo-controlled clinical trial

Germany

Therapeutic confirmatory (Phase III) EU CTIS Study details

The safety and efficacy of acute subcutaneous administration of semaglutide in non-diabetic patients with acute ischemic stroke: a multicentre, phase 2, prospective, randomized, open-label, blinded endpoint trial (ASSET)

Denmark

Therapeutic exploratory (Phase II) EU CTIS Study details

Intra-Arterial thrombolysis after SUCCESSful angiographic recanalization in acute large vessel occlusion stroke of the anterior circulation: the IA-SUCCESS multicenter, randomized clinical trial

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

Phase 2/3 Adaptive Design, Randomized Double-blind Placebo-controlled Study to Evaluate the Safety and Efficacy of DM199 for the Treatment of Acute Ischemic Stroke (ReMEDy2 Trial)

Romania, Hungary, Belgium, Poland, Spain, France

Phase II and Phase III (Integrated) EU CTIS Study details

GREEN A randomized, double-blind, multi-center, placebo-controlled, efficacity and safety study of glenzocimab used as an add-on therapy on top of mechanical thrombectomy for acute ischemic stroke

France

Phase II and Phase III (Integrated) EU CTIS Study details

Acute Ischemic Stroke trials by city

Acute Ischemic Stroke in Toronto Acute Ischemic Stroke in Vancouver Acute Ischemic Stroke in Montreal Acute Ischemic Stroke in Calgary Acute Ischemic Stroke in Edmonton Acute Ischemic Stroke in Ottawa Acute Ischemic Stroke in Winnipeg Acute Ischemic Stroke in Quebec City Acute Ischemic Stroke in Hamilton Acute Ischemic Stroke in Kitchener Acute Ischemic Stroke in London Acute Ischemic Stroke in Halifax Acute Ischemic Stroke in New York Acute Ischemic Stroke in Los Angeles Acute Ischemic Stroke in Chicago Acute Ischemic Stroke in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease